MI Bioresearch Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

2017-11-22
Price :
Published : Nov-2017
No. of Pages : 20

Summary

MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous models, orthotopic models, metastasis models, disseminated models and PDX models. MI also offers services such as validation, candidate selection, optimization, modeling, PK/ PD profiling, biodistribution, custom models, consulting, and ex-vivo. The institute serves pharmaceutical, diagnostics, and medical device sectors. Molecular Imaging is headquartered in Ann Arbor, Michigan, the US.

MI Bioresearch Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides......
$1000

Peanut Allergy: Epidemiology Forecast to 2027

Peanut Allergy: Epidemiology Forecast to 2027 Summary Peanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E (IgE) mediated type-I hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The minimum dose of exposure to elicit an allergic response is highly variable, with some people only requiring trace amounts for a severe reaction. GlobalData epidemiologists provide a 10-year epidemiological forecast for the probable diagnosed prevalent cases of peanut allergy by age and sex, as well as the probable diagnosed prevalent cases of peanut allergy with associated comorbidity, and ......
$3995

Hyperthyroidism Global Clinical Trials Review, H1, 2018

Hyperthyroidism Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Hyperthyroidism Global Clinical Trials Review, H1, 2018" provides an overview of Hyperthyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018" provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500

Hypothyroidism Global Clinical Trials Review, H1, 2018

Hypothyroidism Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Hypothyroidism Global Clinical Trials Review, H1, 2018" provides an overview of Hypothyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on Hypothyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Male Hypogonadism Global Clinical Trials Review, H1, 2018

Male Hypogonadism Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Male Hypogonadism Global Clinical Trials Review, H1, 2018" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Secondary (Hypogonadotropic) Hypogonadism Global Clinical Trials Review, H1, 2018

Secondary (Hypogonadotropic) Hypogonadism Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Secondary (Hypogonadotropic) Hypogonadism Global Clinical Trials Review, H1, 2018" provides an overview of Secondary (Hypogonadotropic) Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Secondary (Hypogonadotropic) Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial ......
$2500

Urinary Incontinence Global Clinical Trials Review, H1, 2018

Urinary Incontinence Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Urinary Incontinence Global Clinical Trials Review, H1, 2018" provides an overview of Urinary Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Incontinence. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinic......
$2500

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2018

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral T-Cell Lymphomas (PTCL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using ......
$2500

Peritoneal Cancer Global Clinical Trials Review, H1, 2018

Peritoneal Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peritoneal Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy